Ramipril and Thalomid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ramipril (ramipril) and Thalomid (thalidomide). Common drug interactions include hypoxia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Ramipril and Thalomid. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.

What is Thalomid?

Thalomid has active ingredients of thalidomide. It is often used in multiple myeloma. eHealthMe is studying from 38,099 Thalomid users. Check the latest studies of Thalomid.



On Jul, 17, 2026

41 people who take Ramipril and Thalomid together, and have interactions are studied.

Ramipril and Thalomid drug interactions.

What are the common drug interactions of Ramipril and Thalomid, by gender? *:

female:

  1. Hypoxia (low oxygen in tissues)
  2. Impaired gastric emptying
  3. Impaired healing
  4. Injury
  5. International normalised ratio decreased
  6. Intervertebral disc degeneration (spinal disc degeneration)
  7. Irritable bowel syndrome
  8. Joint lock
  9. Lethargy (tiredness)
  10. Local swelling (swelling at the site of some application of substance or injury)

male:

  1. Anaemia (lack of blood)
  2. Constipation
  3. Occult blood positive
  4. Osteomyelitis (infection of bone)
  5. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  6. Staphylococcal bacteraemia (a bacterial infection of blood)
  7. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  8. Cardiac failure
  9. Leukocytosis (increased white blood cells)
  10. Neuropathy peripheral (surface nerve damage)

What are the common drug interactions of Ramipril and Thalomid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Osteonecrosis of jaw (death of bone of jaw)
  2. Device related infection
  3. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  4. Malignant melanoma (skin cancer rises from melancytes)
  5. Metastatic malignant melanoma (spreadable cancer tumour of melanine)
  6. Neuropathy peripheral (surface nerve damage)

60+:

  1. Anaemia (lack of blood)
  2. Constipation
  3. Clavicle fracture
  4. Death
  5. Decreased appetite
  6. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  7. Disease progression
  8. Myalgia (muscle pain)
  9. Nail injury
  10. Nodal arrhythmia (an irregular heart beat originating from within the atrioventricular node)

What are the existing conditions these people have? *

  1. Anaemia (lack of blood): 7 people, 17.07%
  2. Diabetes: 5 people, 12.20%
  3. Primary Myelofibrosis (primary disorder of the bone marrow): 4 people, 9.76%
  4. High Blood Cholesterol: 4 people, 9.76%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 9.76%
  6. Pain: 3 people, 7.32%
  7. Necrosis (the death of body tissue): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and Thalomid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ramipril and Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ramipril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thalomid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ramipril and thalidomide (the active ingredients of Ramipril and Thalomid, respectively), and Ramipril and Thalomid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: